Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion

Journal article

Peer reviewed

Nicole M Ehrhardt, Vanita R Aroda, Rodolfo J Galindo, Anne L Peters and Jay H Shubrook

Clinical diabetes, Vol.42(2), p.341

2024

PMID: 38666194

Metrics

2 Record Views

Title: Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion
Creators: Nicole M Ehrhardt - University of Washington
Vanita R Aroda - Brigham and Women's Hospital
Rodolfo J Galindo - University of Miami Health System
Anne L Peters - Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA
Jay H Shubrook - Touro University California
Publication Details: Clinical diabetes, Vol.42(2), p.341
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 38666194
Record Identifier: 991032028589902976